A popular drug currently approved to treat Type 2 diabetes could soon also be approved for weight loss.
Eli Lilly, the maker of the drug Mounjaro, said Thursday it expects the medication could be approved by the U.S. Food and Drug Administration for weight loss as early as the end of the year.
Prior studies among people with obesity without Type 2 diabetes have shown a weight loss within the range of 15% to 21%, depending on the dose of the medication given. Doctors will typically start out with a low dose of the injection and increase the dose after four weeks based on your body's response.Sandy Huffaker for The Washington Post via Getty Images
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Rep. Eli Crane rips federal agency over tribal mine delaysRep. Eli Crane wrote to Interior Secretary Deb Haaland to encourage the feds to cut red tape holding up the tribe's mines.
Lire la suite »
FDA grants accelerated approval to Biogen treatment for rare form of ALSThe FDA has deemed Biogen's torferson reasonably likely to produce a clinical benefit for patients.
Lire la suite »
Outdoor dining with your dog is safe, according to the FDAAccording to this new FDA guidance, you can have your bark with your bite.
Lire la suite »
FDA Gives Fast-Track Approval to New ALS DrugThe FDA fast-tracked the approval on the basis of early trial results.
Lire la suite »
FDA Approves Injectable Treatment for Cheek Lines, WrinklesFDA has approved injectable poly-L-lactic acid for the correction of fine lines and wrinkles in the cheek, the manufacturer announced today. AntiAging FineLineFighter
Lire la suite »
Don't use 'amniotic fluid' eye drops, FDA warns'Amniotic fluid' eye drops aren't approved and could be harmful, the Food and Drug Administration warned.
Lire la suite »